These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21872921)

  • 1. Stents and failing vein grafts: are we any wiser after ISAR?
    Taggart DP; Banning AP
    Lancet; 2011 Sep; 378(9796):1054-5. PubMed ID: 21872921
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
    Mehilli J; Pache J; Abdel-Wahab M; Schulz S; Byrne RA; Tiroch K; Hausleiter J; Seyfarth M; Ott I; Ibrahim T; Fusaro M; Laugwitz KL; Massberg S; Neumann FJ; Richardt G; Schömig A; Kastrati A;
    Lancet; 2011 Sep; 378(9796):1071-8. PubMed ID: 21872918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting versus bare-metal stents for saphenous vein graft lesions.
    Conte SM; Florisson DS; De Bono JA; Vale PR
    Intern Med J; 2019 Dec; 49(12):1534-1537. PubMed ID: 31808253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent implantation in saphenous vein grafts.
    Lozano I; Avanzas P; Rondan J
    Am J Cardiol; 2009 Apr; 103(7):1042-3. PubMed ID: 19327440
    [No Abstract]   [Full Text] [Related]  

  • 5. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.
    Jim MH; Ho HH; Ko RL; Siu CW; Yiu KH; Lau CP; Chow WH
    J Interv Cardiol; 2010 Feb; 23(1):40-5. PubMed ID: 20465719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions.
    Rozenman Y
    JACC Cardiovasc Interv; 2011 May; 4(5):590-1; author reply 591-3. PubMed ID: 21596337
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-eluting versus bare-metal stents in saphenous vein graft lesions.
    Brilakis ES; Banerjee S; Shunk KA; Bhatt DL
    Lancet; 2012 Feb; 379(9816):615; author reply 615-6. PubMed ID: 22340298
    [No Abstract]   [Full Text] [Related]  

  • 8. Are our patients better off with drug-eluting stents in saphenous vein grafts?
    Douglas JS
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1113-5. PubMed ID: 19926053
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting stents for saphenous vein graft lesions.
    Hakeem A; Helmy T; Leesar M; Arif I
    JACC Cardiovasc Interv; 2011 May; 4(5):590; author reply 591-3. PubMed ID: 21596336
    [No Abstract]   [Full Text] [Related]  

  • 10. Saphenous vein graft interventions: drug-eluting stents are better and safe but not good enough.
    Brilakis ES; Banerjee S
    Catheter Cardiovasc Interv; 2012 May; 79(6):910-1. PubMed ID: 22511377
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparing Drug-Eluting Stents to Bare-Metal Stents for Saphenous Vein Graft Lesion PCI.
    Banerjee S; Brilakis ES
    J Invasive Cardiol; 2016 Dec; 28(12):E170-E171. PubMed ID: 27922807
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: bare metal stents versus drug-eluting stents for saphenous vein grafts-an interventionalist's dilemma!
    Satpathy R
    J Interv Cardiol; 2011 Apr; 24(2):181-3. PubMed ID: 21457327
    [No Abstract]   [Full Text] [Related]  

  • 13. Revitalizing embolic protection in saphenous vein grafts.
    Satler LF
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):270-1. PubMed ID: 20665876
    [No Abstract]   [Full Text] [Related]  

  • 14. The unrelenting challenge of vein graft disease.
    Hermiller JB
    J Invasive Cardiol; 2010 Jun; 22(6):258-9. PubMed ID: 20516503
    [No Abstract]   [Full Text] [Related]  

  • 15. Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stent of saphenous vein grafts trial.
    Heuser RR
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):594. PubMed ID: 21351235
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
    Bansal D; Sachdeva R; Mehta JL
    J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of SVG disease: are we missing the point (and an opportunity)?
    Safian RD
    Catheter Cardiovasc Interv; 2012 May; 79(6):919-20. PubMed ID: 22511378
    [No Abstract]   [Full Text] [Related]  

  • 18. DES in SVGs: safe and at least short-term effective.
    Hillegass WB
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):356-7. PubMed ID: 21328680
    [No Abstract]   [Full Text] [Related]  

  • 19. Vessel diameter should be taken into account in saphenous stenting.
    Lozano I; Rondan J; Avanzas P
    EuroIntervention; 2010 Apr; 5(8):991-3. PubMed ID: 20542787
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients.
    Hakeem A; Helmy T; Munsif S; Bhatti S; Mazraeshahi R; Cilingiroglu M; Effat M; Leesar M; Arif I
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):343-55. PubMed ID: 21328679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.